FDA Inspection
Molecular PharmaGroupMolecular PharmaGroup – FDA Inspection, Aug 11, 2025
Record Details
This FDA Inspection record concerns Molecular PharmaGroup, with an inspection on August 11, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 970503e4-df94-4018-a388-f7a3f0943923
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1278107
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.180(e)(1)Review of representative number of batches
- 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Molecular PharmaGroup
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 11, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Molecular PharmaGroup
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.